Avanos Medical, Inc. (NYSE: AVNS) Stock Competitors & Peer Comparison
See AVNS's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for AVNS and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| AVNS | $24.99 | +0.04% | 1.2B | 27.77 | $0.90 | N/A |
| ABT | $109.93 | -3.23% | 190.3B | 21.10 | $5.21 | +2.28% |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| MDT | $101.80 | -2.90% | 130.2B | 18.41 | $5.53 | +2.81% |
| SYK | $325.87 | -2.75% | 124.1B | 24.34 | $13.39 | +1.09% |
| BSX | $42.75 | -4.23% | 62B | 13.79 | $3.10 | N/A |
| EW | $102.14 | +1.31% | 58.9B | 37.82 | $2.70 | N/A |
| GEHC | $82.38 | -1.64% | 37.2B | 16.81 | $4.90 | +0.18% |
| PHG | $30.35 | -0.52% | 29.7B | 17.34 | $1.75 | +3.27% |
| DXCM | $79.41 | -5.98% | 29.6B | 31.14 | $2.55 | N/A |
Stock Comparison
Abbott Laboratories (NYSE: ABT)
AVNS vs ABT Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, ABT has a market cap of 190.3B. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while ABT trades at $109.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas ABT's P/E ratio is 21.10. In terms of profitability, AVNS's ROE is -0.09%, compared to ABT's ROE of +0.09%. Regarding short-term risk, AVNS is less volatile compared to ABT. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check ABT's competition here
Boston Scientific Corporation (NYSE: BSX-PA)
AVNS vs BSX-PA Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, AVNS's ROE is -0.09%, compared to BSX-PA's ROE of +0.14%. Regarding short-term risk, AVNS is less volatile compared to BSX-PA. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check BSX-PA's competition here
Medtronic Plc (NYSE: MDT)
AVNS vs MDT Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, MDT has a market cap of 130.2B. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while MDT trades at $101.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas MDT's P/E ratio is 18.41. In terms of profitability, AVNS's ROE is -0.09%, compared to MDT's ROE of +0.11%. Regarding short-term risk, AVNS is less volatile compared to MDT. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check MDT's competition here
Stryker Corporation (NYSE: SYK)
AVNS vs SYK Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, SYK has a market cap of 124.1B. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while SYK trades at $325.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas SYK's P/E ratio is 24.34. In terms of profitability, AVNS's ROE is -0.09%, compared to SYK's ROE of +0.16%. Regarding short-term risk, AVNS is less volatile compared to SYK. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check SYK's competition here
Boston Scientific Corporation (NYSE: BSX)
AVNS vs BSX Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, BSX has a market cap of 62B. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while BSX trades at $42.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas BSX's P/E ratio is 13.79. In terms of profitability, AVNS's ROE is -0.09%, compared to BSX's ROE of +0.14%. Regarding short-term risk, AVNS is less volatile compared to BSX. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check BSX's competition here
Edwards Lifesciences Corporation (NYSE: EW)
AVNS vs EW Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, EW has a market cap of 58.9B. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while EW trades at $102.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas EW's P/E ratio is 37.82. In terms of profitability, AVNS's ROE is -0.09%, compared to EW's ROE of +0.10%. Regarding short-term risk, AVNS is less volatile compared to EW. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check EW's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
AVNS vs GEHC Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, GEHC has a market cap of 37.2B. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while GEHC trades at $82.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas GEHC's P/E ratio is 16.81. In terms of profitability, AVNS's ROE is -0.09%, compared to GEHC's ROE of +0.16%. Regarding short-term risk, AVNS is less volatile compared to GEHC. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check GEHC's competition here
Koninklijke Philips N.V. (NYSE: PHG)
AVNS vs PHG Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, PHG has a market cap of 29.7B. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while PHG trades at $30.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas PHG's P/E ratio is 17.34. In terms of profitability, AVNS's ROE is -0.09%, compared to PHG's ROE of +0.08%. Regarding short-term risk, AVNS is less volatile compared to PHG. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check PHG's competition here
DexCom, Inc. (NASDAQ: DXCM)
AVNS vs DXCM Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, DXCM has a market cap of 29.6B. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while DXCM trades at $79.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas DXCM's P/E ratio is 31.14. In terms of profitability, AVNS's ROE is -0.09%, compared to DXCM's ROE of +0.37%. Regarding short-term risk, AVNS is less volatile compared to DXCM. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check DXCM's competition here
Zimmer Biomet Holdings, Inc. (NYSE: ZBH)
AVNS vs ZBH Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, ZBH has a market cap of 20.1B. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while ZBH trades at $105.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas ZBH's P/E ratio is 12.45. In terms of profitability, AVNS's ROE is -0.09%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, AVNS is less volatile compared to ZBH. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check ZBH's competition here
Abiomed, Inc. (NASDAQ: ABMD)
AVNS vs ABMD Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas ABMD's P/E ratio is 65.36. In terms of profitability, AVNS's ROE is -0.09%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, AVNS is less volatile compared to ABMD. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check ABMD's competition here
Glaukos Corporation (NYSE: GKOS)
AVNS vs GKOS Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, GKOS has a market cap of 13.3B. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while GKOS trades at $224.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas GKOS's P/E ratio is -260.83. In terms of profitability, AVNS's ROE is -0.09%, compared to GKOS's ROE of -0.25%. Regarding short-term risk, AVNS is less volatile compared to GKOS. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check GKOS's competition here
Smith & Nephew plc (NYSE: SNN)
AVNS vs SNN Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, SNN has a market cap of 13.1B. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while SNN trades at $31.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas SNN's P/E ratio is 21.03. In terms of profitability, AVNS's ROE is -0.09%, compared to SNN's ROE of +0.12%. Regarding short-term risk, AVNS is less volatile compared to SNN. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check SNN's competition here
Penumbra, Inc. (NYSE: PEN)
AVNS vs PEN Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, PEN has a market cap of 12.6B. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while PEN trades at $319.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas PEN's P/E ratio is 83.37. In terms of profitability, AVNS's ROE is -0.09%, compared to PEN's ROE of +0.10%. Regarding short-term risk, AVNS is less volatile compared to PEN. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check PEN's competition here
ShockWave Medical, Inc. (NASDAQ: SWAV)
AVNS vs SWAV Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas SWAV's P/E ratio is 78.76. In terms of profitability, AVNS's ROE is -0.09%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, AVNS is more volatile compared to SWAV. This indicates higher risk in terms of short-term price fluctuations for AVNS.Check SWAV's competition here
Align Technology, Inc. (NASDAQ: ALGN)
AVNS vs ALGN Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, ALGN has a market cap of 11.8B. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while ALGN trades at $166.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas ALGN's P/E ratio is 15.14. In terms of profitability, AVNS's ROE is -0.09%, compared to ALGN's ROE of +0.12%. Regarding short-term risk, AVNS is less volatile compared to ALGN. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check ALGN's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO)
AVNS vs BIO Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, BIO has a market cap of 10.2B. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while BIO trades at $381.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas BIO's P/E ratio is 41.12. In terms of profitability, AVNS's ROE is -0.09%, compared to BIO's ROE of +0.14%. Regarding short-term risk, AVNS is less volatile compared to BIO. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check BIO's competition here
Insulet Corp. (NASDAQ: PODD)
AVNS vs PODD Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, PODD has a market cap of 10.2B. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while PODD trades at $146.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas PODD's P/E ratio is 24.96. In terms of profitability, AVNS's ROE is -0.09%, compared to PODD's ROE of +0.29%. Regarding short-term risk, AVNS is less volatile compared to PODD. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check PODD's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO-B)
AVNS vs BIO-B Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, BIO-B has a market cap of 9.9B. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while BIO-B trades at $374.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas BIO-B's P/E ratio is -65.97. In terms of profitability, AVNS's ROE is -0.09%, compared to BIO-B's ROE of +0.14%. Regarding short-term risk, AVNS is less volatile compared to BIO-B. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check BIO-B's competition here
Globus Medical, Inc. (NYSE: GMED)
AVNS vs GMED Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, GMED has a market cap of 9.5B. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while GMED trades at $71.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas GMED's P/E ratio is 16.00. In terms of profitability, AVNS's ROE is -0.09%, compared to GMED's ROE of +0.12%. Regarding short-term risk, AVNS is less volatile compared to GMED. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check GMED's competition here
Masimo Corporation (NASDAQ: MASI)
AVNS vs MASI Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, MASI has a market cap of 9.4B. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while MASI trades at $179.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas MASI's P/E ratio is 44.43. In terms of profitability, AVNS's ROE is -0.09%, compared to MASI's ROE of +0.09%. Regarding short-term risk, AVNS is more volatile compared to MASI. This indicates higher risk in terms of short-term price fluctuations for AVNS.Check MASI's competition here
Bruker Corporation (NASDAQ: BRKR)
AVNS vs BRKR Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, BRKR has a market cap of 9.3B. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while BRKR trades at $61.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas BRKR's P/E ratio is 30.81. In terms of profitability, AVNS's ROE is -0.09%, compared to BRKR's ROE of -0.05%. Regarding short-term risk, AVNS is less volatile compared to BRKR. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check BRKR's competition here
Bruker Corporation (NASDAQ: BRKRP)
AVNS vs BRKRP Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, BRKRP has a market cap of 9.3B. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while BRKRP trades at $446.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas BRKRP's P/E ratio is 244.34. In terms of profitability, AVNS's ROE is -0.09%, compared to BRKRP's ROE of -0.05%. Regarding short-term risk, AVNS is less volatile compared to BRKRP. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check BRKRP's competition here
Haemonetics Corporation (NYSE: HAE)
AVNS vs HAE Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, HAE has a market cap of 5.5B. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while HAE trades at $119.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas HAE's P/E ratio is 23.93. In terms of profitability, AVNS's ROE is -0.09%, compared to HAE's ROE of +0.12%. Regarding short-term risk, AVNS is less volatile compared to HAE. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check HAE's competition here
LivaNova PLC (NASDAQ: LIVN)
AVNS vs LIVN Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, LIVN has a market cap of 4.9B. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while LIVN trades at $89.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas LIVN's P/E ratio is 21.37. In terms of profitability, AVNS's ROE is -0.09%, compared to LIVN's ROE of +0.15%. Regarding short-term risk, AVNS is less volatile compared to LIVN. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check LIVN's competition here
Inari Medical, Inc. (NASDAQ: NARI)
AVNS vs NARI Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas NARI's P/E ratio is -59.24. In terms of profitability, AVNS's ROE is -0.09%, compared to NARI's ROE of -0.00%. Regarding short-term risk, AVNS is more volatile compared to NARI. This indicates higher risk in terms of short-term price fluctuations for AVNS.Check NARI's competition here
Integer Holdings Corporation (NYSE: ITGR)
AVNS vs ITGR Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, ITGR has a market cap of 4.3B. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while ITGR trades at $126.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas ITGR's P/E ratio is 19.94. In terms of profitability, AVNS's ROE is -0.09%, compared to ITGR's ROE of +0.06%. Regarding short-term risk, AVNS is less volatile compared to ITGR. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check ITGR's competition here
TransMedics Group, Inc. (NASDAQ: TMDX)
AVNS vs TMDX Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, TMDX has a market cap of 3.1B. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while TMDX trades at $88.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas TMDX's P/E ratio is 44.77. In terms of profitability, AVNS's ROE is -0.09%, compared to TMDX's ROE of +0.28%. Regarding short-term risk, AVNS is less volatile compared to TMDX. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check TMDX's competition here
AxoGen, Inc. (NASDAQ: AXGN)
AVNS vs AXGN Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, AXGN has a market cap of 3B. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while AXGN trades at $50.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas AXGN's P/E ratio is 131.53. In terms of profitability, AVNS's ROE is -0.09%, compared to AXGN's ROE of -0.11%. Regarding short-term risk, AVNS is less volatile compared to AXGN. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check AXGN's competition here
iRhythm Technologies, Inc. (NASDAQ: IRTC)
AVNS vs IRTC Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, IRTC has a market cap of 3B. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while IRTC trades at $90.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas IRTC's P/E ratio is -209.53. In terms of profitability, AVNS's ROE is -0.09%, compared to IRTC's ROE of -0.23%. Regarding short-term risk, AVNS is less volatile compared to IRTC. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check IRTC's competition here
Neogen Corporation (NASDAQ: NEOG)
AVNS vs NEOG Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, NEOG has a market cap of 2.6B. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while NEOG trades at $11.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas NEOG's P/E ratio is 42.00. In terms of profitability, AVNS's ROE is -0.09%, compared to NEOG's ROE of -0.03%. Regarding short-term risk, AVNS is less volatile compared to NEOG. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check NEOG's competition here
UFP Technologies, Inc. (NASDAQ: UFPT)
AVNS vs UFPT Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, UFPT has a market cap of 2.3B. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while UFPT trades at $303.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas UFPT's P/E ratio is 30.94. In terms of profitability, AVNS's ROE is -0.09%, compared to UFPT's ROE of +0.17%. Regarding short-term risk, AVNS is less volatile compared to UFPT. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check UFPT's competition here
NuVasive, Inc. (NASDAQ: NUVA)
AVNS vs NUVA Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas NUVA's P/E ratio is 75.00. In terms of profitability, AVNS's ROE is -0.09%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, AVNS is less volatile compared to NUVA. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check NUVA's competition here
Establishment Labs Holdings Inc. (NASDAQ: ESTA)
AVNS vs ESTA Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, ESTA has a market cap of 2B. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while ESTA trades at $67.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas ESTA's P/E ratio is -53.24. In terms of profitability, AVNS's ROE is -0.09%, compared to ESTA's ROE of -2.04%. Regarding short-term risk, AVNS is less volatile compared to ESTA. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check ESTA's competition here
Inspire Medical Systems, Inc. (NYSE: INSP)
AVNS vs INSP Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, INSP has a market cap of 1.9B. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while INSP trades at $63.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas INSP's P/E ratio is 28.18. In terms of profitability, AVNS's ROE is -0.09%, compared to INSP's ROE of +0.12%. Regarding short-term risk, AVNS is less volatile compared to INSP. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check INSP's competition here
Butterfly Network, Inc. (NYSE: BFLY)
AVNS vs BFLY Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, BFLY has a market cap of 1.7B. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while BFLY trades at $6.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas BFLY's P/E ratio is -26.52. In terms of profitability, AVNS's ROE is -0.09%, compared to BFLY's ROE of -0.28%. Regarding short-term risk, AVNS is less volatile compared to BFLY. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check BFLY's competition here
Enovis Corporation (NYSE: ENOV)
AVNS vs ENOV Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, ENOV has a market cap of 1.6B. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while ENOV trades at $27.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas ENOV's P/E ratio is 7.77. In terms of profitability, AVNS's ROE is -0.09%, compared to ENOV's ROE of -0.36%. Regarding short-term risk, AVNS is less volatile compared to ENOV. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check ENOV's competition here
Novocure Ltd (NASDAQ: NVCR)
AVNS vs NVCR Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, NVCR has a market cap of 1.6B. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while NVCR trades at $13.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas NVCR's P/E ratio is -12.52. In terms of profitability, AVNS's ROE is -0.09%, compared to NVCR's ROE of -0.36%. Regarding short-term risk, AVNS is less volatile compared to NVCR. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check NVCR's competition here
CONMED Corporation (NYSE: CNMD)
AVNS vs CNMD Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, CNMD has a market cap of 1.5B. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while CNMD trades at $51.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas CNMD's P/E ratio is 11.32. In terms of profitability, AVNS's ROE is -0.09%, compared to CNMD's ROE of +0.07%. Regarding short-term risk, AVNS is less volatile compared to CNMD. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check CNMD's competition here
Heska Corporation (NASDAQ: HSKA)
AVNS vs HSKA Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas HSKA's P/E ratio is -62.49. In terms of profitability, AVNS's ROE is -0.09%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, AVNS is more volatile compared to HSKA. This indicates higher risk in terms of short-term price fluctuations for AVNS.Check HSKA's competition here
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI)
AVNS vs LMRI Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, LMRI has a market cap of 1.3B. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while LMRI trades at $13.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas LMRI's P/E ratio is -26.07. In terms of profitability, AVNS's ROE is -0.09%, compared to LMRI's ROE of -0.06%. Regarding short-term risk, AVNS is less volatile compared to LMRI. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check LMRI's competition here
Tandem Diabetes Care, Inc. (NASDAQ: TNDM)
AVNS vs TNDM Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, TNDM has a market cap of 1.2B. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while TNDM trades at $16.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas TNDM's P/E ratio is -18.18. In terms of profitability, AVNS's ROE is -0.09%, compared to TNDM's ROE of -0.36%. Regarding short-term risk, AVNS is less volatile compared to TNDM. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check TNDM's competition here
PROCEPT BioRobotics Corporation (NASDAQ: PRCT)
AVNS vs PRCT Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, PRCT has a market cap of 1.2B. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while PRCT trades at $20.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas PRCT's P/E ratio is -10.62. In terms of profitability, AVNS's ROE is -0.09%, compared to PRCT's ROE of -0.33%. Regarding short-term risk, AVNS is less volatile compared to PRCT. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check PRCT's competition here
Alphatec Holdings, Inc. (NASDAQ: ATEC)
AVNS vs ATEC Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, ATEC has a market cap of 1.2B. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while ATEC trades at $7.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas ATEC's P/E ratio is -13.21. In terms of profitability, AVNS's ROE is -0.09%, compared to ATEC's ROE of -5.47%. Regarding short-term risk, AVNS is less volatile compared to ATEC. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check ATEC's competition here
Silk Road Medical, Inc (NASDAQ: SILK)
AVNS vs SILK Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas SILK's P/E ratio is -18.96. In terms of profitability, AVNS's ROE is -0.09%, compared to SILK's ROE of -0.35%. Regarding short-term risk, AVNS is more volatile compared to SILK. This indicates higher risk in terms of short-term price fluctuations for AVNS.Check SILK's competition here
Paragon 28, Inc. (NYSE: FNA)
AVNS vs FNA Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas FNA's P/E ratio is -19.83. In terms of profitability, AVNS's ROE is -0.09%, compared to FNA's ROE of -0.35%. Regarding short-term risk, AVNS is less volatile compared to FNA. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check FNA's competition here
IRadimed Corporation (NASDAQ: IRMD)
AVNS vs IRMD Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, IRMD has a market cap of 1.1B. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while IRMD trades at $86.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas IRMD's P/E ratio is 43.16. In terms of profitability, AVNS's ROE is -0.09%, compared to IRMD's ROE of +0.24%. Regarding short-term risk, AVNS is less volatile compared to IRMD. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check IRMD's competition here
SI-BONE, Inc. (NASDAQ: SIBN)
AVNS vs SIBN Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, SIBN has a market cap of 1.1B. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while SIBN trades at $24.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas SIBN's P/E ratio is -71.29. In terms of profitability, AVNS's ROE is -0.09%, compared to SIBN's ROE of -0.08%. Regarding short-term risk, AVNS is less volatile compared to SIBN. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check SIBN's competition here
Integra LifeSciences Holdings Corporation (NASDAQ: IART)
AVNS vs IART Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, IART has a market cap of 1B. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while IART trades at $13.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas IART's P/E ratio is 5.69. In terms of profitability, AVNS's ROE is -0.09%, compared to IART's ROE of +0.01%. Regarding short-term risk, AVNS is less volatile compared to IART. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check IART's competition here
CeriBell, Inc. (NASDAQ: CBLL)
AVNS vs CBLL Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, CBLL has a market cap of 1B. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while CBLL trades at $26.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas CBLL's P/E ratio is -15.12. In terms of profitability, AVNS's ROE is -0.09%, compared to CBLL's ROE of -0.55%. Regarding short-term risk, AVNS is less volatile compared to CBLL. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check CBLL's competition here
AdaptHealth Corp. (NASDAQ: AHCO)
AVNS vs AHCO Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, AHCO has a market cap of 998.7M. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while AHCO trades at $7.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas AHCO's P/E ratio is 14.95. In terms of profitability, AVNS's ROE is -0.09%, compared to AHCO's ROE of -0.29%. Regarding short-term risk, AVNS is less volatile compared to AHCO. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check AHCO's competition here
Artivion, Inc. (NYSE: AORT)
AVNS vs AORT Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, AORT has a market cap of 985.1M. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while AORT trades at $20.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas AORT's P/E ratio is 33.67. In terms of profitability, AVNS's ROE is -0.09%, compared to AORT's ROE of -0.04%. Regarding short-term risk, AVNS is less volatile compared to AORT. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check AORT's competition here
Picard Medical, Inc. (AMEX: PMI)
AVNS vs PMI Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, PMI has a market cap of 877.7M. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while PMI trades at $9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas PMI's P/E ratio is -7.12. In terms of profitability, AVNS's ROE is -0.09%, compared to PMI's ROE of -9.31%. Regarding short-term risk, AVNS is less volatile compared to PMI. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check PMI's competition here
Cardiovascular Systems, Inc. (NASDAQ: CSII)
AVNS vs CSII Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, CSII has a market cap of 844M. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas CSII's P/E ratio is -20.83. In terms of profitability, AVNS's ROE is -0.09%, compared to CSII's ROE of -0.14%. Regarding short-term risk, AVNS is less volatile compared to CSII. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check CSII's competition here
OrthoPediatrics Corp. (NASDAQ: KIDS)
AVNS vs KIDS Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, KIDS has a market cap of 829.5M. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while KIDS trades at $31.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas KIDS's P/E ratio is -23.71. In terms of profitability, AVNS's ROE is -0.09%, compared to KIDS's ROE of -0.10%. Regarding short-term risk, AVNS is less volatile compared to KIDS. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check KIDS's competition here
Varex Imaging Corporation (NASDAQ: VREX)
AVNS vs VREX Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, VREX has a market cap of 783.4M. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while VREX trades at $18.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas VREX's P/E ratio is 19.42. In terms of profitability, AVNS's ROE is -0.09%, compared to VREX's ROE of +0.05%. Regarding short-term risk, AVNS is less volatile compared to VREX. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check VREX's competition here
InMode Ltd. (NASDAQ: INMD)
AVNS vs INMD Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, INMD has a market cap of 767.6M. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while INMD trades at $13.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas INMD's P/E ratio is 9.26. In terms of profitability, AVNS's ROE is -0.09%, compared to INMD's ROE of +0.12%. Regarding short-term risk, AVNS is less volatile compared to INMD. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check INMD's competition here
Cytek Biosciences, Inc. (NASDAQ: CTKB)
AVNS vs CTKB Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, CTKB has a market cap of 760.4M. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while CTKB trades at $5.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas CTKB's P/E ratio is -30.99. In terms of profitability, AVNS's ROE is -0.09%, compared to CTKB's ROE of -0.25%. Regarding short-term risk, AVNS is less volatile compared to CTKB. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check CTKB's competition here
Bioventus Inc. (NASDAQ: BVS)
AVNS vs BVS Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, BVS has a market cap of 725.1M. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while BVS trades at $10.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas BVS's P/E ratio is 13.93. In terms of profitability, AVNS's ROE is -0.09%, compared to BVS's ROE of +0.27%. Regarding short-term risk, AVNS is less volatile compared to BVS. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check BVS's competition here
Beta Bionics, Inc. (NASDAQ: BBNX)
AVNS vs BBNX Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, BBNX has a market cap of 706.8M. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while BBNX trades at $15.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas BBNX's P/E ratio is -8.54. In terms of profitability, AVNS's ROE is -0.09%, compared to BBNX's ROE of -0.27%. Regarding short-term risk, AVNS is less volatile compared to BBNX. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check BBNX's competition here
Pacific Biosciences of California, Inc. (NASDAQ: PACB)
AVNS vs PACB Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, PACB has a market cap of 700.9M. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while PACB trades at $2.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas PACB's P/E ratio is -5.50. In terms of profitability, AVNS's ROE is -0.09%, compared to PACB's ROE of +6.04%. Regarding short-term risk, AVNS is less volatile compared to PACB. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check PACB's competition here
Surmodics, Inc. (NASDAQ: SRDX)
AVNS vs SRDX Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while SRDX trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas SRDX's P/E ratio is -34.66. In terms of profitability, AVNS's ROE is -0.09%, compared to SRDX's ROE of -0.10%. Regarding short-term risk, AVNS is more volatile compared to SRDX. This indicates higher risk in terms of short-term price fluctuations for AVNS.Check SRDX's competition here
Tactile Systems Technology, Inc. (NASDAQ: TCMD)
AVNS vs TCMD Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, TCMD has a market cap of 583.1M. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while TCMD trades at $26.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas TCMD's P/E ratio is 24.10. In terms of profitability, AVNS's ROE is -0.09%, compared to TCMD's ROE of +0.11%. Regarding short-term risk, AVNS is less volatile compared to TCMD. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check TCMD's competition here
Apollo Endosurgery, Inc. (NASDAQ: APEN)
AVNS vs APEN Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas APEN's P/E ratio is -9.43. In terms of profitability, AVNS's ROE is -0.09%, compared to APEN's ROE of -0.85%. Regarding short-term risk, AVNS is less volatile compared to APEN. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check APEN's competition here
Sight Sciences, Inc. (NASDAQ: SGHT)
AVNS vs SGHT Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, SGHT has a market cap of 556.4M. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while SGHT trades at $10.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas SGHT's P/E ratio is -18.04. In terms of profitability, AVNS's ROE is -0.09%, compared to SGHT's ROE of -0.52%. Regarding short-term risk, AVNS is less volatile compared to SGHT. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check SGHT's competition here
Anteris Technologies Global Corp. (NASDAQ: AVR)
AVNS vs AVR Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, AVR has a market cap of 554.1M. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while AVR trades at $5.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas AVR's P/E ratio is -2.93. In terms of profitability, AVNS's ROE is -0.09%, compared to AVR's ROE of -0.78%. Regarding short-term risk, AVNS is less volatile compared to AVR. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check AVR's competition here
ZimVie Inc. (NASDAQ: ZIMV)
AVNS vs ZIMV Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while ZIMV trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, AVNS's ROE is -0.09%, compared to ZIMV's ROE of -0.07%. Regarding short-term risk, AVNS is more volatile compared to ZIMV. This indicates higher risk in terms of short-term price fluctuations for AVNS.Check ZIMV's competition here
Delcath Systems, Inc. (NASDAQ: DCTH)
AVNS vs DCTH Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, DCTH has a market cap of 518.4M. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while DCTH trades at $14.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas DCTH's P/E ratio is 1494.00. In terms of profitability, AVNS's ROE is -0.09%, compared to DCTH's ROE of +0.00%. Regarding short-term risk, AVNS is less volatile compared to DCTH. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check DCTH's competition here
Senseonics Holdings, Inc. (NASDAQ: SENS)
AVNS vs SENS Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, SENS has a market cap of 453.7M. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while SENS trades at $8.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas SENS's P/E ratio is -3.85. In terms of profitability, AVNS's ROE is -0.09%, compared to SENS's ROE of -1.66%. Regarding short-term risk, AVNS is less volatile compared to SENS. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check SENS's competition here
SS Innovations International, Inc. (NASDAQ: SSII)
AVNS vs SSII Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, SSII has a market cap of 430M. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while SSII trades at $2.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas SSII's P/E ratio is -35.75. In terms of profitability, AVNS's ROE is -0.09%, compared to SSII's ROE of -0.27%. Regarding short-term risk, AVNS is less volatile compared to SSII. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check SSII's competition here
NeuroPace, Inc. (NASDAQ: NPCE)
AVNS vs NPCE Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, NPCE has a market cap of 428.4M. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while NPCE trades at $12.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas NPCE's P/E ratio is -21.89. In terms of profitability, AVNS's ROE is -0.09%, compared to NPCE's ROE of -1.20%. Regarding short-term risk, AVNS is less volatile compared to NPCE. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check NPCE's competition here
Avita Medical Inc. (NASDAQ: RCEL)
AVNS vs RCEL Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, RCEL has a market cap of 412.4M. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while RCEL trades at $16.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas RCEL's P/E ratio is -11.53. In terms of profitability, AVNS's ROE is -0.09%, compared to RCEL's ROE of +1.46%. Regarding short-term risk, AVNS is less volatile compared to RCEL. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check RCEL's competition here
Cerus Corporation (NASDAQ: CERS)
AVNS vs CERS Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, CERS has a market cap of 406.9M. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while CERS trades at $2.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas CERS's P/E ratio is -66.94. In terms of profitability, AVNS's ROE is -0.09%, compared to CERS's ROE of -0.11%. Regarding short-term risk, AVNS is less volatile compared to CERS. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check CERS's competition here
CapsoVision, Inc. (NASDAQ: CV)
AVNS vs CV Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, CV has a market cap of 336M. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while CV trades at $6.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas CV's P/E ratio is -10.02. In terms of profitability, AVNS's ROE is -0.09%, compared to CV's ROE of -1.78%. Regarding short-term risk, AVNS is less volatile compared to CV. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check CV's competition here
Orthofix Medical Inc. (NASDAQ: OFIX)
AVNS vs OFIX Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, OFIX has a market cap of 317.9M. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while OFIX trades at $7.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas OFIX's P/E ratio is -5.12. In terms of profitability, AVNS's ROE is -0.09%, compared to OFIX's ROE of -0.14%. Regarding short-term risk, AVNS is less volatile compared to OFIX. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check OFIX's competition here
Semler Scientific, Inc. (NASDAQ: SMLR)
AVNS vs SMLR Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while SMLR trades at $20.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas SMLR's P/E ratio is 3.92. In terms of profitability, AVNS's ROE is -0.09%, compared to SMLR's ROE of +0.20%. Regarding short-term risk, AVNS is more volatile compared to SMLR. This indicates higher risk in terms of short-term price fluctuations for AVNS.Check SMLR's competition here
ClearPoint Neuro, Inc. (NASDAQ: CLPT)
AVNS vs CLPT Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, CLPT has a market cap of 275.5M. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while CLPT trades at $8.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas CLPT's P/E ratio is -7.28. In terms of profitability, AVNS's ROE is -0.09%, compared to CLPT's ROE of -1.70%. Regarding short-term risk, AVNS is less volatile compared to CLPT. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check CLPT's competition here
InfuSystem Holdings, Inc. (AMEX: INFU)
AVNS vs INFU Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, INFU has a market cap of 273.5M. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while INFU trades at $13.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas INFU's P/E ratio is 33.49. In terms of profitability, AVNS's ROE is -0.09%, compared to INFU's ROE of +0.16%. Regarding short-term risk, AVNS is less volatile compared to INFU. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check INFU's competition here
Profound Medical Corp. (NASDAQ: PROF)
AVNS vs PROF Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, PROF has a market cap of 263.8M. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while PROF trades at $7.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas PROF's P/E ratio is -7.37. In terms of profitability, AVNS's ROE is -0.09%, compared to PROF's ROE of -0.28%. Regarding short-term risk, AVNS is less volatile compared to PROF. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check PROF's competition here
Quantum-Si incorporated (NASDAQ: QSI)
AVNS vs QSI Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, QSI has a market cap of 263.6M. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while QSI trades at $1.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas QSI's P/E ratio is -2.88. In terms of profitability, AVNS's ROE is -0.09%, compared to QSI's ROE of -0.45%. Regarding short-term risk, AVNS is less volatile compared to QSI. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check QSI's competition here
Treace Medical Concepts, Inc. (NASDAQ: TMCI)
AVNS vs TMCI Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, TMCI has a market cap of 262.7M. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while TMCI trades at $4.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas TMCI's P/E ratio is -4.30. In terms of profitability, AVNS's ROE is -0.09%, compared to TMCI's ROE of -0.76%. Regarding short-term risk, AVNS is less volatile compared to TMCI. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check TMCI's competition here
Monogram Orthopaedics, Inc. (NASDAQ: MGRM)
AVNS vs MGRM Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, MGRM has a market cap of 243.8M. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while MGRM trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas MGRM's P/E ratio is -12.00. In terms of profitability, AVNS's ROE is -0.09%, compared to MGRM's ROE of -1.17%. Regarding short-term risk, AVNS is more volatile compared to MGRM. This indicates higher risk in terms of short-term price fluctuations for AVNS.Check MGRM's competition here
Nevro Corp. (NYSE: NVRO)
AVNS vs NVRO Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas NVRO's P/E ratio is -1.91. In terms of profitability, AVNS's ROE is -0.09%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, AVNS is less volatile compared to NVRO. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check NVRO's competition here
Electromed, Inc. (AMEX: ELMD)
AVNS vs ELMD Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, ELMD has a market cap of 223.4M. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while ELMD trades at $27.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas ELMD's P/E ratio is 20.58. In terms of profitability, AVNS's ROE is -0.09%, compared to ELMD's ROE of +0.23%. Regarding short-term risk, AVNS is less volatile compared to ELMD. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check ELMD's competition here
TriSalus Life Sciences, Inc. (NASDAQ: TLSI)
AVNS vs TLSI Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, TLSI has a market cap of 199.5M. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while TLSI trades at $3.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas TLSI's P/E ratio is -1.93. In terms of profitability, AVNS's ROE is -0.09%, compared to TLSI's ROE of +2.74%. Regarding short-term risk, AVNS is less volatile compared to TLSI. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check TLSI's competition here
BioSig Technologies, Inc. (NASDAQ: BSGM)
AVNS vs BSGM Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, BSGM has a market cap of 191.1M. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while BSGM trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas BSGM's P/E ratio is -5.81. In terms of profitability, AVNS's ROE is -0.09%, compared to BSGM's ROE of +6.96%. Regarding short-term risk, AVNS is less volatile compared to BSGM. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check BSGM's competition here
RxSight, Inc. (NASDAQ: RXST)
AVNS vs RXST Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, RXST has a market cap of 188.6M. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while RXST trades at $4.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas RXST's P/E ratio is -4.01. In terms of profitability, AVNS's ROE is -0.09%, compared to RXST's ROE of -0.20%. Regarding short-term risk, AVNS is less volatile compared to RXST. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check RXST's competition here
Xylo Technologies Ltd. (NASDAQ: MDGS)
AVNS vs MDGS Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while MDGS trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas MDGS's P/E ratio is -0.27. In terms of profitability, AVNS's ROE is -0.09%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, AVNS is less volatile compared to MDGS. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check MDGS's competition here
Neuronetics, Inc. (NASDAQ: STIM)
AVNS vs STIM Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, STIM has a market cap of 163.4M. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while STIM trades at $2.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas STIM's P/E ratio is -4.87. In terms of profitability, AVNS's ROE is -0.09%, compared to STIM's ROE of -1.28%. Regarding short-term risk, AVNS is less volatile compared to STIM. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check STIM's competition here
Quipt Home Medical Corp. (NASDAQ: QIPT)
AVNS vs QIPT Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while QIPT trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas QIPT's P/E ratio is -15.87. In terms of profitability, AVNS's ROE is -0.09%, compared to QIPT's ROE of -0.08%. Regarding short-term risk, AVNS is more volatile compared to QIPT. This indicates higher risk in terms of short-term price fluctuations for AVNS.Check QIPT's competition here
Inogen, Inc. (NASDAQ: INGN)
AVNS vs INGN Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, INGN has a market cap of 160M. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while INGN trades at $6.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas INGN's P/E ratio is -6.63. In terms of profitability, AVNS's ROE is -0.09%, compared to INGN's ROE of -0.20%. Regarding short-term risk, AVNS is less volatile compared to INGN. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check INGN's competition here
Quanterix Corporation (NASDAQ: QTRX)
AVNS vs QTRX Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, QTRX has a market cap of 137.1M. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while QTRX trades at $2.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas QTRX's P/E ratio is -1.14. In terms of profitability, AVNS's ROE is -0.09%, compared to QTRX's ROE of -0.44%. Regarding short-term risk, AVNS is less volatile compared to QTRX. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check QTRX's competition here
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL)
AVNS vs FOCL Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, FOCL has a market cap of 125.9M. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while FOCL trades at $3.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas FOCL's P/E ratio is -3.25. In terms of profitability, AVNS's ROE is -0.09%, compared to FOCL's ROE of -2.41%. Regarding short-term risk, AVNS is less volatile compared to FOCL. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check FOCL's competition here
Owlet, Inc. (NYSE: OWLT)
AVNS vs OWLT Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, OWLT has a market cap of 121.6M. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while OWLT trades at $4.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas OWLT's P/E ratio is -29.71. In terms of profitability, AVNS's ROE is -0.09%, compared to OWLT's ROE of -0.50%. Regarding short-term risk, AVNS is less volatile compared to OWLT. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check OWLT's competition here
Pulmonx Corporation (NASDAQ: LUNG)
AVNS vs LUNG Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, LUNG has a market cap of 109.9M. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while LUNG trades at $2.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas LUNG's P/E ratio is -2.53. In terms of profitability, AVNS's ROE is -0.09%, compared to LUNG's ROE of -0.98%. Regarding short-term risk, AVNS is less volatile compared to LUNG. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check LUNG's competition here
iCAD, Inc. (NASDAQ: ICAD)
AVNS vs ICAD Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while ICAD trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas ICAD's P/E ratio is -20.37. In terms of profitability, AVNS's ROE is -0.09%, compared to ICAD's ROE of -0.18%. Regarding short-term risk, AVNS is more volatile compared to ICAD. This indicates higher risk in terms of short-term price fluctuations for AVNS.Check ICAD's competition here
Hancock Jaffe Laboratories (NASDAQ: HJLI)
AVNS vs HJLI Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, HJLI has a market cap of 98.3M. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while HJLI trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas HJLI's P/E ratio is N/A. In terms of profitability, AVNS's ROE is -0.09%, compared to HJLI's ROE of -0.70%. Regarding short-term risk, AVNS is less volatile compared to HJLI. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check HJLI's competition here
Perspective Therapeutics, Inc. (AMEX: CATX)
AVNS vs CATX Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, CATX has a market cap of 95.9M. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while CATX trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas CATX's P/E ratio is -0.63. In terms of profitability, AVNS's ROE is -0.09%, compared to CATX's ROE of -0.42%. Regarding short-term risk, AVNS is less volatile compared to CATX. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check CATX's competition here
Asensus Surgical, Inc. (AMEX: ASXC)
AVNS vs ASXC Comparison November 2026
Avanos Medical, Inc. (NYSE: AVNS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVNS stands at 1.2B. In comparison, ASXC has a market cap of 94.9M. Regarding current trading prices, AVNS is priced at $24.99 on the NYSE, while ASXC trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVNS currently has a P/E ratio of 27.77, whereas ASXC's P/E ratio is -1.12. In terms of profitability, AVNS's ROE is -0.09%, compared to ASXC's ROE of -1.18%. Regarding short-term risk, AVNS is less volatile compared to ASXC. This indicates lower risk in terms of short-term price fluctuations for AVNS.Check ASXC's competition here